Hyperinflammation in airways of cystic fibrosis patients: what’s new?

References

• Tirouvanziam R. Neutrophilic inflammation as a major determinant in the progression of cystic fibrosis. Drug News Perspect.19(10), 609–614 (2006).
   PubMedGoogle Scholar
• Kreda SM, Mall M, Mengos A et al. Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol. Biol. Cell16(5), 2154–2167 (2005).
   PubMed Web of Science ®Google Scholar
• Jacquot J, Puchelle E, Hinnrasky J et al. Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands. Eur. Respir. J.6(2), 169–176 (1993).
   PubMed Web of Science ®Google Scholar
• Chmiel JF, Davis PB. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can’t they clear the infection? Respir. Res.4(1), 8 (2003).
   PubMed Web of Science ®Google Scholar
• Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N. Engl. J. Med.354(3), 241–250 (2006).
   PubMed Web of Science ®Google Scholar
• Boucher RC. Cystic fibrosis: a disease of vulnerability to airway surface dehydration. Trends Mol. Med.13(6), 231–240 (2007).
   PubMed Web of Science ®Google Scholar
• Reiniger N, Lee MM, Coleman FT, Ray C, Golan DE, Pier GB. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect. Immun.75(4), 1598–1608 (2007).
   PubMedGoogle Scholar
• Ornatowski W, Poschet JF, Perkett E, Taylor-Cousar JL, Deretic V. Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicity. J. Clin. Invest.117(11), 3489–3497 (2007).
   PubMed Web of Science ®Google Scholar
• Teichgraber V, Ulrich M, Endlich N et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat. Med.14(4), 382–391 (2008).
   PubMed Web of Science ®Google Scholar
• Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am. J. Respir. Crit. Care Med.154(5), 1229–1256 (1996).
   PubMed Web of Science ®Google Scholar
• Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr. Pulmonol.20(2), 63–70 (1995).
   PubMed Web of Science ®Google Scholar
• Sagel SD, Chmiel JF, Konstan MW. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc. Am. Thorac. Soc.4(4), 406–417 (2007).
   PubMedGoogle Scholar
• Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur. Respir. J.23(1), 146–158 (2004).
   PubMed Web of Science ®Google Scholar
• Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am. J. Respir. Crit. Care Med.160(1), 186–191 (1999).
   PubMed Web of Science ®Google Scholar
• Tirouvanziam R, de Bentzmann S, Hubeau C et al. Inflammation and infection in naive human cystic fibrosis airway grafts. Am. J. Respir. Cell. Mol. Biol.23(2), 121–127 (2000).
   PubMedGoogle Scholar
• Elizur A, Cannon CL, Ferkol TW. Airway inflammation in cystic fibrosis. Chest133(2), 489–495 (2008).
   PubMed Web of Science ®Google Scholar
• Tabary O, Escotte S, Couetil JP et al. High susceptibility for cystic fibrosis human airway gland cells to produce IL-8 through the IκB kinase α pathway in response to extracellular NaCl content. J. Immunol.164(6), 3377–3384 (2000).
   PubMed Web of Science ®Google Scholar
• Tabary O, Escotte S, Couetil JP et al. Relationship between IκBα deficiency, NFκB activity and interleukin-8 production in CF human airway epithelial cells. Pflugers Arch.443(Suppl. 1), S40–S44 (2001).
   PubMedGoogle Scholar
• Tabary O, Zahm JM, Hinnrasky J et al. Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro.Am. J. Pathol.153(3), 921–930 (1998).
   PubMed Web of Science ®Google Scholar
• Carrabino S, Carpani D, Livraghi A et al. Dysregulated interleukin-8 secretion and NF-κB activity in human cystic fibrosis nasal epithelial cells. J. Cyst. Fibros.5(2), 113–119 (2006).
   PubMed Web of Science ®Google Scholar
• Eidelman O, Srivastava M, Zhang J et al. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-αR/NFκB pathway. Mol. Med.7(8), 523–534 (2001).
   PubMed Web of Science ®Google Scholar
• Wiszniewski L, Jornot L, Dudez T et al. Long-term cultures of polarized airway epithelial cells from patients with cystic fibrosis. Am. J. Respir. Cell. Mol. Biol.34(1), 39–48 (2006).
   PubMed Web of Science ®Google Scholar
• Muhlebach MS, Reed W, Noah TL. Quantitative cytokine gene expression in CF airway. Pediatr. Pulmonol.37(5), 393–399 (2004).
   PubMedGoogle Scholar
• Hallows KR, Fitch AC, Richardson CA et al. Up-regulation of AMP-activated kinase by dysfunctional cystic fibrosis transmembrane conductance regulator in cystic fibrosis airway epithelial cells mitigates excessive inflammation. J. Biol. Chem.281(7), 4231–4241 (2006).
   PubMed Web of Science ®Google Scholar
• Tabary O, Escotte S, Couetil JP et al. Genistein inhibits constitutive and inducible NFκB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells. Am. J. Pathol.155(2), 473–481 (1999).
   PubMed Web of Science ®Google Scholar
• DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A. Activation of NF-κB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J. Clin. Invest.101(11), 2598–2605 (1998).
   PubMed Web of Science ®Google Scholar
• Tabary O, Muselet C, Escotte S et al. Interleukin-10 inhibits elevated chemokine interleukin-8 and regulated on activation normal T cell expressed and secreted production in cystic fibrosis bronchial epithelial cells by targeting the IκB kinase a/b complex. Am. J. Pathol.162(1), 293–302 (2003).
   PubMed Web of Science ®Google Scholar
• Kube D, Sontich U, Fletcher D, Davis PB. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am. J. Physiol. Lung Cell. Mol. Physiol.280(3), L493–L502 (2001).
   PubMed Web of Science ®Google Scholar
• Meduri GU, Kanangat S, Stefan J, Tolley E, Schaberg D. Cytokines IL-1β, IL-6, and TNF-α enhance in vitro growth of bacteria. 160(3), 961–967 (1999).
   Google Scholar
• Groux-Degroote S, Krzewinski-Recchi MA, Cazet A et al. IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewis x epitopes in the human bronchial mucosa. Biochem. J.410(1), 213–223 (2007).
   Google Scholar
• Verhaeghe C, Remouchamps C, Hennuy B et al. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochem. Pharmacol.73(12), 1982–1994 (2007).
   PubMed Web of Science ®Google Scholar
• Pollard HB, Ji XD, Jozwik C, Jacobowitz DM. High abundance protein profiling of cystic fibrosis lung epithelial cells. Proteomics5(8), 2210–2226 (2005).
   PubMed Web of Science ®Google Scholar
• Weber AJ, Soong G, Bryan R, Saba S, Prince A. Activation of NF-κB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function. Am. J. Physiol. Lung Cell. Mol. Physiol.281(1), L71–L78 (2001).
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan A, Stecenko AA, King G et al. Exaggerated activation of nuclear factor-κB and altered IκB-β processing in cystic fibrosis bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol.23(3), 396–403 (2000).
   PubMed Web of Science ®Google Scholar
• Srivastava M, Eidelman O, Joswik C et al. Serum proteomic signature for cystic fibrosis using an antibody microarray platform. Mol. Genet. Metab.87(4), 303–310 (2006).
   PubMed Web of Science ®Google Scholar
• Saadane A, Masters S, DiDonato J, Li J, Berger M. Parthenolide inhibits IκB kinase, NF-κB activation, and inflammatory response in cystic fibrosis cells and mice. Am. J. Respir. Cell. Mol. Biol.36(6), 728–736 (2007).
   PubMed Web of Science ®Google Scholar
• Chmiel JF, Konstan MW. Anti-inflammatory medications for cystic fibrosis lung disease: selecting the most appropriate agent. Treat. Respir. Med.4(4), 255–273 (2005).
   PubMedGoogle Scholar
• Chmiel JF, Konstan MW, Knesebeck JE et al. IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. Am. J. Respir. Crit. Care Med.160(6), 2040–2047 (1999).
   PubMed Web of Science ®Google Scholar
• Perez A, Issler AC, Cotton CU, Kelley TJ, Verkman AS, Davis PB. CFTR inhibition mimics the cystic fibrosis inflammatory profile. Am. J. Physiol. Lung Cell. Mol. Physiol.292(2), L383–L395 (2007).
   PubMed Web of Science ®Google Scholar
• Ollero M, Junaidi O, Zaman MM et al. Decreased expression of peroxisome proliferator activated receptor γ in CFTR-/- mice. J. Cell Physiol.200(2), 235–244 (2004).
   PubMedGoogle Scholar
• Sadikot RT, Christman JW, Blackwell TS. Molecular targets for modulating lung inflammation and injury. Curr. Drug Targets5(6), 581–588 (2004).
   PubMedGoogle Scholar
• Boncoeur E, Criq VS, Bonvin E et al. Oxidative stress induces extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase in cystic fibrosis lung epithelial cells: potential mechanism for excessive IL-8 expression. Int. J. Biochem. Cell Biol.40(3), 432–446 (2008).
   PubMed Web of Science ®Google Scholar
• Boncoeur E, Tabary O, Bonvin E et al. Oxidative stress response results in increased p21WAF1/CIP1 degradation in cystic fibrosis lung epithelial cells. Free Radic. Biol. Med.40(1), 75–86 (2006).
   PubMedGoogle Scholar
• Jacquot J, Tabary O, Le Rouzic P, Clement A. Airway epithelial cell inflammatory signalling in cystic fibrosis. Int. J. Biochem. Cell Biol. (Epub ahead of print) (2008).
   Google Scholar
• Jensen PO, Bjarnsholt T, Phipps R et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa.Microbiology153(Pt 5), 1329–1338 (2007).
   PubMed Web of Science ®Google Scholar
• Hartl D, Latzin P, Hordijk P et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat. Med.13(12), 1423–1430 (2007).
   PubMed Web of Science ®Google Scholar
• Voynow JA, Fischer BM, Zheng S. Proteases and cystic fibrosis. Int. J. Biochem. Cell Biol.40(6–7), 1238–1245 (2008).
   PubMed Web of Science ®Google Scholar
• Kettle AJ, Chan T, Osberg I et al. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am. J. Respir. Crit. Care Med.170(12), 1317–1323 (2004).
   PubMed Web of Science ®Google Scholar
• Adib-Conquy M, Pedron T, Petit-Bertron AF et al. Neutrophils in cystic fibrosis display a distinct gene expression pattern. Mol. Med.14(1–2), 36–44 (2008).
   PubMed Web of Science ®Google Scholar
• Tabary O, Corvol H, Boncoeur E et al. Adherence of airway neutrophils and inflammatory response are increased in CF airway epithelial cell-neutrophil interactions. Am. J. Physiol. Lung Cell. Mol. Physiol.290(3), L588–L596 (2006).
   Google Scholar
• Tirouvanziam R, Gernez Y, Conrad CK et al. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc. Natl Acad. Sci. USA105(11), 4335–4339 (2008).
   PubMedGoogle Scholar